Education
About Us
Working with TipRanks
Follow Us
Matthew W. Davis Insider Profile
4 Followers
Matthew W. Davis, Chief Development Officer at Aquestive Therapeutics, holds 50.00K shares in Aquestive Therapeutics (Ticker: AQST).
Matthew W. Davis has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Matthew W. Davis's holdings
Insider Roles
Chief Development Officer
Roles that Matthew W. Davis holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Matthew W. Davis
Matthew W. Davis's Trading History
List of latest transactions for each holding click on a transaction to see Matthew W. Davis's performance on stock
You May Also Like
Matthew W. Davis insider profile FAQ
What is the percentage of profitable transactions made by Matthew W. Davis?
The percentage of profitable transactions made by Matthew W. Davis is ―.
What is the average return per transaction made by Matthew W. Davis?
The average return per transaction made by Matthew W. Davis is ―.
What stocks does Matthew W. Davis hold?
Matthew W. Davis holds: AQST stocks.
What was Matthew W. Davis’s latest transaction?
Matthew W. Davis latest transaction was an Uninformative Buy of ―.
What was Matthew W. Davis's most profitable transaction?
Matthew W. Davis’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Matthew W. Davis's role in Aquestive Therapeutics?
Matthew W. Davis's role in Aquestive Therapeutics is Chief Development Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.